ZERO WINTERDEAL 2025: Bis zu 300 € Prämie + Gratis-Aktie + finanzen.net MSCI World-ETF -
Jetzt informieren!
NASDAQ 100
25.368,63
PKT
+271,21
PKT
+1,08
%
Indikation*
25.358,16
PKT
+260,75
PKT
+1,04
%
Offiziell
Werbung
Analysen zu NASDAQ 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 04.05.12 | Linde neutral | WestLB AG | |
| 04.05.12 | Linde buy | Commerzbank Corp. & Markets | |
| 04.05.12 | Linde buy | Sarasin Research | |
| 04.05.12 | Linde halten | National-Bank AG | |
| 04.05.12 | Apple overweight | JP Morgan Chase & Co. | |
| 04.05.12 | Microchip Technology overweight | Barclays Capital | |
| 03.05.12 | Comcast buy | UBS AG | |
| 03.05.12 | Biogen overweight | Barclays Capital | |
| 03.05.12 | Biogen buy | Jefferies & Company Inc. | |
| 03.05.12 | Fiserv sector perform | RBC Capital Markets | |
| 03.05.12 | Cisco sector perform | RBC Capital Markets | |
| 03.05.12 | Biogen outperform | RBC Capital Markets | |
| 03.05.12 | ON Semiconductor buy | D.A. Davidson & Co. | |
| 03.05.12 | Biogen overweight | Morgan Stanley | |
| 03.05.12 | Microsoft outperform | Sanford C. Bernstein and Co., Inc. | |
| 02.05.12 | Amazon buy | SunTrust Robinson Humphrey, Inc. | |
| 02.05.12 | Linde buy | Société Générale Group S.A. (SG) | |
| 02.05.12 | Apple overweight | Barclays Capital | |
| 02.05.12 | Gilead Sciences outperform | RBC Capital Markets | |
| 02.05.12 | Cognizant overweight | Barclays Capital | |
| 02.05.12 | Starbucks sector perform | RBC Capital Markets | |
| 02.05.12 | KLA-Tencor outperform | Exane-BNP Paribas SA | |
| 02.05.12 | O Reilly Automotive outperform | RBC Capital Markets | |
| 02.05.12 | QUALCOMM outperform | Macquarie Research | |
| 30.04.12 | Amazon buy | Citigroup Corp. | |
| 30.04.12 | Apple halten | Independent Research GmbH | |
| 30.04.12 | Charter A buy | Nomura | |
| 30.04.12 | Amazon outperform | RBC Capital Markets | |
| 30.04.12 | Dollar Tree buy | BB&T Capital Markets | |
| 30.04.12 | Amazon equal-weight | Barclays Capital | |
| 30.04.12 | Amazon overweight | JP Morgan Chase & Co. | |
| 30.04.12 | Vertex Pharmaceuticals overweight | Barclays Capital | |
| 30.04.12 | Amazon buy | Banc of America Securities-Merrill Lynch | |
| 30.04.12 | Amazon buy | Jefferies & Company Inc. | |
| 30.04.12 | Baker Hughes kaufen | Die Actien-Börse | |
| 30.04.12 | Gilead Sciences buy | Citigroup Corp. | |
| 30.04.12 | Gilead Sciences outperform | Needham & Company, LLC | |
| 30.04.12 | Amazon outperform | Oppenheimer & Co. Inc. | |
| 30.04.12 | Starbucks buy | Deutsche Bank Securities | |
| 30.04.12 | Amazon overweight | Piper Jaffray & Co. |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.